pioglitazone

Compared with rats that received sham irradiation, irradiated rats that did not receive pioglitazone displayed cognitive impairment.

We did not observe similar associations in a secondary analysis evaluating pioglitazone.

"The PROACTIVE data went in the right direction, so I would say pioglitazone was probably safe, " he said.

The other is combine pioglitazone with vitamin E compare to vitamin E alone to see how these drugs work in the long term.

Rosiglitazone and pioglitazone are part of a group of drugs called thiazolidinediones.

Like insulin and other diabetes drugs, rosiglitazone and a similar drug, pioglitazone (Actos), lower blood sugar.

Pioglitazone clearly has fallen on the side of cardiovascular benefits or very close.

International Diabetes: Do rosiglitazone and pioglitazone have different or similar properties in respect to their cardiovascular profiles?

Has some of the bad press and issues with rosiglitazone unfairly affected pioglitazone?

In addition, Actos (pioglitazone), a drug used to treat diabetes, also improved many features of NASH but was associated with weight gain.

Objective To observe the effects of pioglitazone on stent restenosis in coronary heart disease patients with impaired glucose tolerance.

International Diabetes: Does pioglitazone have more favorable effects on serum lipids than rosiglitazone?

By contrast, no drop in cognitive function was observed in irradiated animals treated with pioglitazone.

No difference between rosiglitazone and pioglitazone was apparent.

It was financed in part by Takeda Pharmaceuticals, maker of pioglitazone.

Pioglitazone was tested in combination with a sulfonylurea, insulin, or metformin in 8 trials (8501 patients).

Effects of combined treatment with glimepiride and pioglitazone on metabolic syndrome patients with type 2 diabetes mellitus.

Beginning in 1999, rosiglitazone maleate and pioglitazone hydrochloride were approved for use.

Objective To explore the effects of Pioglitazone in Treatment of non-alcoholic fatty liver disease with type 2 diabetes mellitus.

Certainly, in heart failure it has cardiovascular mortality which was not seen with the pioglitazone heart failure group.

Patients taking pioglitazone averaged 380 days of medication, and patients taking rosiglitazone averaged 369 days of medication.

Pioglitazone and metformin have both proven safe and efficacious in the treatment of type 2 diabetes.

TABLE 2 lists the clinical outcome measures in the pioglitazone and control groups of the 19 individual trials.

Insulin sensitivity in the liver improved by 48 percent in the pioglitazone group, compared to 14 percent in the placebo group.

I would choose in this order metformin, pioglitazone, GLP-1 compound and then insulin.

When you look at the composite meta-analysis data for pioglitazone, it falls on the good side.

My personal view is that pioglitazone should stay on the market and just be used a little more carefully.

Bioequivalence assessment of pioglitazone hydrochloride oral preparation by limited sampling strategy

Studies on the Dissolution Rates of Pioglitazone Hydrochloride Tablets Preparation from Different Manufactures

Research to manufacture the Pioglitazone Hydrochloride orally disintegrating tablets

Determination of Organic Residual Solvents in Pioglitazone Hydrochloride by Capillary Gas Chromatography

Effects of pioglitazone on expression of myocardial proinflammatory cytokine in left ventricular hypertrophic rats

Simultaneous determination of pioglitazone and its two active metabolites in human plasma by HPLC-MS

Effects of pioglitazone and irbesartan on vascular smooth muscle cells proliferation induced by advanced glycation end products

Pioglitazone on fibrinolytic system in elderly hypertensive patients with insulin resistance

Preventive effects of pioglitazone on diabetes and relevant mechanisms, experimental study on non-obese diabetic mice

Effects of different dosages of pioglitazone hydrochloride on insulin sensitivity of patients with diabetes

Antiproliferative effects of pioglitazone involved of nitric oxide on cultured rabbit aortic smooth muscle cells

Pharmacokinetics of pioglitazone hydrochloride tablets in healthy human subjects after a single dose administration

Graphical Synthetic Routes of Pioglitazone Hydrochloride

Experimental Study on Affection of Ultra-microstructure of Rat Diabetes Kidney Treated with Pioglitazone

Role of pioglitazone in resolution of monosodium urate monohydrate crystal induced acute gouty arthritis in rats

Effects of pioglitazone on cardiac fibroblast proliferation induced with high glucose and high insulin

Clinical study of homemade pioglitazone in the treatment of patients with type 2 diabetes mellitus

Study on the Impurities in Synthesized Pioglitazone Hydrochloride by HPLC- ESI Ion Trap Mass Spectrometry

Regulatory effects of pioglitazone and fenofibrate on body fat distribution and energy homeostasis in SD rats

Effects of pioglitazone on hypertrophic myocardial cells induced with high glucose and high insulin

Study on the effects of pioglitazone on insulin sensitivity and adiponectin in hyperglycemic fatty rats

Effects of pioglitazone on lipid and glucose metabolism in normal, hyperlipidemia and fatty model rats

Pioglitazone Inhibit Cardiac Hypertrophy Induced by Pressure Overload in Rats

Comparison of Effect and Adverse Reaction of Pioglitazone and Dimethyl Biguanide on Patients with Type 2 Diabetes Mellitus Latest Diagnosed

Clinical observation of metformin combined with pioglitazone in treating newly diagnosed obesity type 2 diabetes patients

Curative effect of pioglitazone on polycystic ovary syndrome with insulin resistance

Then, just several months ago, the FDA put out warning about possible bladder cancer with pioglitazone;

Effects of Pioglitazone on Cytokine Expressions in Synovium in Rats with Acute Gouty Arthritis

Preventive and therapeutic effects of pioglitazone on fatty liver induced by high-fat feeding in rats

Comparison of the efficacy between pioglitazone and metformin in treating type 2 diabetic patients

The effects of pioglitazone on oxidative stress of the kidneys of diabetic rats

Protective effects of pioglitazone on heart in ischemia-reperfusion injury rat

Effects of Pioglitazone on Collagen Synthesis in Cardiac Fibroblasts of Rat

New Synthetic Method of Pioglitazone Hydrochloride

Observation of Clinical Effects of Pioglitazone Hydrochloride in Treatment of Type 2 Diabetic Patients

Study on the prevention of insulin resistance of pioglitazone in the rats induced by high-fat diet

The diverse effects of different dosages of pioglitazone on uninephrectomized diabetic rats

Therapeutic effects of pioglitazone on rat with fatty liver induced by high fat diet

Influence of pioglitazone or metformin on insulin resistance in patients with type 2 diabetes mellitus

Preventive effects of pioglitazone on rat fatty liver induced by a high fat diet

Effects of Pioglitazone on Intima-Medial Thickness of Carotid Artery in Type 2 Diabetic Mellitus Patients

Pioglitazone Improves Cardiovascular Risk Profile of Patients With Type 2 Diabetes

Effects of pioglitazone on the insulin resistance in the muscle tissue

Effect of Pioglitazone on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Mellitus Patients

Protective effects of pioglitazone on renal in diabetic rats

Effect of pioglitazone on retinal cells apoptosis in non-obese diabetic mice

Changes in C-reactive protein in patients with type 2 diabetes after treatment with pioglitazone

Effects of combination of insulin Aspart 30 and pioglitazone hydrochloride on blood glucose in type 2 diabetes mellitus patients

Effects of metformin or pioglitazone combining with insulin in type 2 diabetes mellitus

Therapeutic Effect of Pioglitazone Hydrochloride on the Treatment of Type 2 Diabetes

Efficacy of pioglitazone hydrochloride in treating type 2 diabetes

Effects of pioglitazone on plasma endothelin levels in patients with type 2 diabetes

The profile of serum free fatty acids in patients with type 2 diabetes and the intervention effect of Pioglitazone

Effect of Pioglitazone Hydrochloride on Soluble Vascular Cell Adhesion Molecule-1 in Patients with Type 2 Diabetes Mellitus

Pioglitazone Combined with Insulin in the Treatment of Type 2 Diabetic Patients

Effects of Pioglitazone on Elderly Patients with Type 2 Diabetes Mellitus

Multicenter clinical trial of pioglitazone in the treatment of 2 type diabetes

The Efficacy and Safety of Pioglitazone Hydrochloride in the treatment of 48 Cases with Type 2 Diabetes Mellitus

Effects of Pioglitazone on Serum Matrix Metalloproteinase-9 Levels in Patients with Type 2 Diabetes

Effect of Pioglitazone on Plasminogen Activator Inhibitor-1 of Plasma in Type 2 Diabetic Mellitus Patients

The effect of pioglitazone on plasma adiponectin levels of patients with type 2 diabetes

Effect of pioglitazone on expressions of matrix metalloproteinase 2 and 9 in kidney of diabetic rats

Effect of pioglitazone on serum vascular cell adhesion molecule-1 level in type 2 diabetic patients